Luiza Caramori, MD, PhD, MSc

Associate Professor of Medicine, Division of Diabetes, Endocrinology and Metabolism

Luiza Caramori

Contact Info

Mailing Address:
420 Delaware Street SE
MMC 101
Minneapolis, MN 55455

Administrative Assistant Name
Sommer Wappel

Administrative Phone
612-624-5150

Administrative Email
srduffy@umn.edu

Administrative Fax Number
612-626-3133

Associate Professor of Medicine, Division of Diabetes, Endocrinology and Metabolism


Endocrinologist


Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil

Internal Medicine Residency, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil

Endocrinology Fellowship, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil

Endocrinology and Diabetes Fellowship, University of Minnesota, Minneapolis, MN

Summary

Dr. Luiza Caramori graduated from medical school at the Universidade Federal do Rio Grande do Sul, Brazil and completed a residency in Internal Medicine followed by a clinical fellowship in pediatric and adult Endocrinology. She then completed a Master’s and subsequently PhD. Dr. Caramori was a research fellow in Pediatric Nephrology at the University of Minnesota (1998-2002), and a clinical fellow in Endocrinology and Diabetes (2004-2006). She joined the faculty at the University of Minnesota, and is an Assistant Professor in the Department of Medicine since 2006 and in the Department of Pediatrics since 2007. Dr. Caramori was the recipient of the prestigious JDRF Career Development Award, and is the center PI on a NIH supported clinical trial evaluating the effects of allopurinol in preventing early renal function loss in diabetes. She was also the PI on a JDRF grant evaluating epigenetic changes in diabetes and diabetic nephropathy and the Co-investigator on multiple NIH grants in the area of diabetes and its complications. She is nationally and internationally recognized by her research on diabetic nephropathy.

Awards & Recognition

  • Masters Research Award, Brazilian Superior Education Development Agency (CAPES)
  • PhD Research Award, Brazilian Superior Education Development Agency (CAPES)
  • Post-Doctoral Fellowship Award, Juvenile Diabetes Research Foundation International
  • Career Development Award, Juvenile Diabetes Research Foundation International

Professional Associations

  • Member of the American Diabetes Association
  • Member of the American Society of Nephrology
  • Member of the European Association for the Study of Diabetes
  • Member of the European Diabetic Nephropathy Study Group 

Research

Research Summary/Interests

  • Diabetic Nephropathy
  • Metabolic Memory in Type 1 Diabetes
  • PERL – The consortium received $25 million dollars from NIH to study the potential beneficial effects of allopurinol (a FDA approved drug that reduces uric acid levels) in slowing down renal function decline in patients with type 1 diabetes.
  • FIGARO and FIDELIO – Industry sponsored clinical trials aiming to study the potential beneficial effects of finerenone (a mineralocorticoid receptor antagonist) in the rate of kidney and cardiovascular disease in patients with type 2 diabetes. 

Clinical

Specialties

  • Endocrinology, Diabetes and Metabolism

Clinics

Endocrinology and Diabetes Clinic

Board Certifications

  • Internal Medicine
  • Endocrinology, Diabetes, and Metabolism

Clinical Interests

Diabetes; Endocrinology; Diabetic Nephropathy

Hospital Privileges

University of Minnesota Medical Center, Fairview